These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 11231440)

  • 1. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
    Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
    Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
    Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
    J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR; Neubauer S; Obitz G; Ertl G
    J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of angiotensin II in the renal response to atrial natriuretic peptide in normal subjects.
    Rakugi H; Ogihara T; Nakamaru M; Saito H; Shima J; Sakaguchi K; Kumahara Y
    J Cardiovasc Pharmacol; 1989; 13 Suppl 6():S55-8. PubMed ID: 2473352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atrial natriuretic peptide versus mannitol on renal blood flow during radiocontrast infusion in chronic renal failure.
    Kurnik BR; Weisberg LS; Cuttler IM; Kurnik PB
    J Lab Clin Med; 1990 Jul; 116(1):27-36. PubMed ID: 2142949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acute renal actions of angiotensin converting enzyme inhibitors in the sodium-depleted conscious primate are mediated by inhibition of the renin-angiotensin system.
    Humke U; Levens N; Wood J; Hofbauer K
    J Pharmacol Exp Ther; 1992 Jan; 260(1):29-35. PubMed ID: 1309874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of infusing alpha-atrial natriuretic peptide in primary hypertension during converting enzyme inhibition.
    Agabiti-Rosei E; Castellano M; Beschi M; Muiesan ML; Romanelli G; Rizzoni D; Muiesan G
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S151-3. PubMed ID: 2485053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide counteracts angiotensin-II-induced impairment of renal function.
    Schafferhans K; Heidbreder E; Hummel S; Heidland A
    Z Kardiol; 1988; 77 Suppl 2():78-84. PubMed ID: 2970179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Clin Sci (Lond); 2008 May; 114(10):635-42. PubMed ID: 18052934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic action of ANP is blunted by ACE inhibition in humans.
    Wambach G; Schittenhelm U; Stimpel M; Bönner G; Kaufmann W
    J Cardiovasc Pharmacol; 1989 May; 13(5):748-53. PubMed ID: 2472523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA; Asaad MM; Lanoce VM; Langenbacher KM; Fennell SA; Rogers WL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):872-83. PubMed ID: 8394922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal short-term renal response to acute volume expansion in heart transplant recipients: a role for atrial natriuretic peptide?
    Geny B; Charloux A; Schaefer A; Brandt C; Charpentier A; Kretz JG; Eisenmann B; Haberey P; Piquard F
    J Heart Lung Transplant; 1998 Nov; 17(11):1081-8. PubMed ID: 9855447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of perfusion of human atrial natriuretic factor in normal volunteers].
    Bidiville J; Waeber G; Nussberger J; Biollaz J; Porchet M; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1986 Dec; 116(49):1733-5. PubMed ID: 2949362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men.
    Grandis DJ; Uretsky BF; Verbalis JG; Chong TK; Puschett JB
    Am J Hypertens; 1992 Nov; 5(11):793-9. PubMed ID: 1457079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic peptide reverses experimental acute renal failure induced by arginine vasopressin.
    Heidbreder E; Zollner T; Schafferhans K; Götz R
    Miner Electrolyte Metab; 1990; 16(1):48-53. PubMed ID: 2139164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal and cardiorenal responses to acute saline loading in mild congestive heart failure--the effect of angiotensin converting enzyme inhibition.
    Tomiyama H; Nishikawa E; Watanabe G; Shiojima K; Shimada K; Yamamoto A; Ishikawa Y; Yoshida H; Doba N
    Jpn Circ J; 1998 Jan; 62(1):29-35. PubMed ID: 9559415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
    Packer M
    Circulation; 1988 Jun; 77(6 Pt 2):I64-73. PubMed ID: 2967129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.